Clinical trial · Observational
Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary Aldosteronism
The Cross-sectional Study and Longitudinal Study of the the Value of Adrenocorticotrophic Hormonestimulation in Adrenal Vein Sampling
NCT05826080CI-TRIAL-00065895unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of our research is to evaluate the value of ACTH stimulation in AVS especially in lateralization is still controversial.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Aldosterone-Producing Adenoma | — | UNRESOLVED | — |
| Idiopathic Hyperaldosteronism | — | UNRESOLVED | — |
| Primary Aldosteronism | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- operative group
- description
- Procedure/Surgery:Adrenal Vein Sampling;Adrenalectomy
Primary outcomes (13)
- measure
- Participants' personal information
- timeFrame
- 1 day
- description
- Self-reported information (the cause of discovering adrenal adenoma）
- measure
- Physical assessments
- timeFrame
- 1 day
- description
- BMI(body mess index) in kg/m\^2
- measure
- Screening test of primary aldosteronism（Supine standing test）
- timeFrame
- 1 day
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. Diagnosed as primary aldosteronism. 2. AVS was performed and conservative treatment or adrenalectomy was performed according to the results. 3. Regular follow-up was performed. Exclusion Criteria: 1. Adrenal function evaluation suggests that it is complicated with hypercortisolism, subclinical hypercortisolism and pheochromocytoma. 2. Familial aldosteronism. 3. .Adrenal mass is considered to be malignant, or pathology suggests adrenocortical carcinoma. 4. .Complicated with severe infection, respiratory and circulatory failure, advanced tumor, severe. hepatic and renal insufficiency, neurological, psychiatric and immune deficiency diseases. 5. .Drugs: discontinuation of β-receptor inhibitors, angiotensin converting enzyme inhibitors, angiotensin Ⅱ receptor blockers, thiazide diuretics \< 2 weeks, aldosterone receptor antagonists \< 4 weeks. 6. .Pregnant and lactating women.
References
Publications (0)
Data not yet available
No reference posted for this study.